MAM
VIVO

Meeder Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Meeder Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-188
Closed -$6K – 2182
2022
Q3 		$6K Buy
188
+128
+213% +$4.14K ﹤0.01% 1530
2022
Q2 		$2K Sell
60
-11
-15% -$297 ﹤0.01% 1945
2022
Q1 		$2K Buy
+71
New +$1.69K ﹤0.01% 2116
2021
Q4 		– Sell
-213
Closed -$4K – 2512
2021
Q3 		$4K Buy
213
+42
+25% +$837 ﹤0.01% 2031
2021
Q2 		$4K Sell
171
-166
-49% -$3.52K ﹤0.01% 2051
2021
Q1 		$9K Buy
337
+318
+1,674% +$7.56K ﹤0.01% 1664
2020
Q4 		$0 Sell
19
-1,700
-99% -$31.7K ﹤0.01% 2345
2020
Q3 		$29K Sell
1,719
-1,268
-42% -$24.6K ﹤0.01% 1074
2020
Q2 		$70K Sell
2,987
-2,680
-47% -$38.8K ﹤0.01% 857
2020
Q1 		$49K Sell
5,667
-655
-10% -$5.51K ﹤0.01% 924
2019
Q4 		$62K Buy
6,322
+5,767
+1,039% +$54.1K ﹤0.01% 960
2019
Q3 		$5K Sell
555
-12,025
-96% -$127K ﹤0.01% 1786
2019
Q2 		$150K Buy
12,580
+11,028
+711% +$133K 0.01% 652
2019
Q1 		$27K Buy
1,552
+1,029
+197% +$17.1K ﹤0.01% 1012
2018
Q4 		$9K Buy
523
+37
+8% +$631 ﹤0.01% 1288
2018
Q3 		$7K Sell
486
-313
-39% -$4.85K ﹤0.01% 1262
2018
Q2 		$12.7K Hold
799
– – ﹤0.01% 1078
2018
Q1 		$11K Sell
799
-126
-14% -$1.86K ﹤0.01% 1049
2017
Q4 		$12K Buy
+925
New +$13.5K ﹤0.01% 1085
2016
Q3 		– Sell
-9,702
Closed -$189K – 989
2016
Q2 		$189K Sell
9,702
-12,870
-57% -$252K 0.02% 575
2016
Q1 		$465K Hold
22,572
– – 0.04% 416
2015
Q4 		$463K Sell
22,572
-20,696
-48% -$397K 0.04% 350
2015
Q3 		$739K Buy
+43,268
New +$791K 0.07% 254

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meeder Asset Management's VIVO Position: Q4 2022 in Review

Meeder Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2022, closing a stake of 188 shares — an estimated $6K sold.

Meeder Asset Management first reported a position in VIVO in Q3 2015 and held it in 23 quarters. The position peaked at $739K in Q3 2015. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

  • Meeder Asset Management reported no remaining Meridian Bioscience Inc position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 188 Meridian Bioscience Inc shares in Q4 2022, an estimated $6K.
  • Meeder Asset Management first reported a position in Meridian Bioscience Inc in Q3 2015 and held it in 23 quarters.
  • Meeder Asset Management's Meridian Bioscience Inc position peaked at $739K in Q3 2015.
  • 218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.